Answers are grounded in this paper and cite their sources.
Micropulse Transscleral diode laser cyclophotocoagulation (MP-TSCPC) is an established method of treatment for refractory glaucoma. This study evaluates the efficacy in terms of reduction in intraocular pressure and/or treatment amount, and safety and side effects of the ciliary bodies using a subthreshold laser with a duty cycle of 31.3% with Supra 810 nm Subliminal Quantel Medical, at one year in patients with refractory glaucoma.
No takes yet. Share an insight, caveat, or question.
Hekalo et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: